{"id": "58", "url": "https://fevir.net/resources/Citation/58", "date": "2022-01-10T13:29:15.764Z", "meta": {"versionId": "32", "lastUpdated": "2025-10-13T16:59:33.089Z"}, "title": "Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)", "author": [{"name": "Brian S. Alper"}], "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "summary": [{"text": "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors:  Brian S. Alper,  Joanne Dehnbostel,  Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55.", "style": {"coding": [{"code": "comppub", "system": "http://terminology.hl7.org/CodeSystem/citation-summary-style", "display": "Computable Publishing"}]}}], "contained": [{"id": "contributor0", "name": [{"given": ["Brian S."], "family": "Alper"}], "telecom": [{"value": "balper@computablepublishing.com", "system": "email"}], "identifier": [{"value": "0000-0003-4300-4928", "system": "https://orcid.org/", "assigner": {"display": "ORCID"}}], "resourceType": "Practitioner"}, {"id": "contributor1", "name": [{"given": ["Joanne"], "family": "Dehnbostel"}], "telecom": [{"value": "jdehnbostel@computablepublishing.com", "system": "email"}], "resourceType": "Practitioner"}, {"id": "contributor2", "name": [{"given": ["Khalid"], "family": "Shahin"}], "telecom": [{"value": "kshahin@computablepublishing.com", "system": "email"}], "resourceType": "Practitioner"}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "58", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "useContext": [{"code": {"code": "fevir-platform-use", "system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "display": "FEvIR Platform Use"}, "valueCodeableConcept": {"coding": [{"code": "fhir-resource", "system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "display": "FHIR Resource"}]}}], "resourceType": "Citation", "citedArtifact": {"title": [{"text": "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY).", "type": [{"coding": [{"code": "primary", "system": "http://terminology.hl7.org/CodeSystem/title-type", "display": "Primary title"}]}], "language": {"coding": [{"system": "urn:ietf:bcp:47", "code": "en", "display": "English"}]}}], "version": {"value": "4"}, "abstract": [{"text": "COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis", "type": {"coding": [{"code": "primary-human-use", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-abstract-type", "display": "Primary human use"}]}, "language": {"coding": [{"system": "urn:ietf:bcp:47", "code": "en", "display": "English"}]}, "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/"}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "55", "system": "https://fevir.net", "assigner": {"display": "Computable Publishing LLC"}}], "statusDate": [{"actual": true, "period": {"end": "2020-12-17"}, "activity": {"coding": [{"code": "created", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Created"}]}}], "webLocation": [{"url": "https://fevir.net/resources/Evidence/55", "classifier": [{"coding": [{"code": "json", "system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "display": "JSON"}]}, {"coding": [{"code": "computable-resource", "system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "display": "Computable resource"}]}]}], "dateAccessed": "2021-03-13", "classification": [{"type": {"coding": [{"code": "knowledge-artifact-type", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Knowledge Artifact Type"}]}, "classifier": [{"coding": [{"code": "fhir-resource", "system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "display": "FHIR Resource"}]}]}, {"type": {"text": "fhir-resource"}, "classifier": [{"coding": [{"code": "Evidence", "system": "http://hl7.org/fhir/fhir-types", "display": "Evidence"}]}]}, {"type": {"text": "defined-in-text"}, "classifier": [{"text": "remdesivir", "coding": [{"code": "defined-in-text", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Defined in text"}]}, {"text": "COVID-19", "coding": [{"code": "defined-in-text", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Defined in text"}]}, {"text": "pharmaceutical treatment", "coding": [{"code": "defined-in-text", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Defined in text"}]}]}], "contributorship": {"entry": [{"role": {"coding": [{"code": "author", "system": "http://hl7.org/fhir/contributor-role", "display": "Author/Creator"}]}, "affiliation": [{"display": "Computable Publishing LLC"}], "contributor": {"type": "Practitioner", "reference": "#contributor0"}, "contributionType": [{"coding": [{"code": "conceptualization", "system": "http://hl7.org/fhir/artifact-contribution-type", "display": "Conceptualization"}]}, {"coding": [{"code": "data-curation", "system": "http://hl7.org/fhir/artifact-contribution-type", "display": "Data curation"}]}, {"coding": [{"code": "supervision", "system": "http://hl7.org/fhir/artifact-contribution-type", "display": "Supervision"}]}], "forenameInitials": "BS", "correspondingContact": true}, {"role": {"coding": [{"code": "author", "system": "http://hl7.org/fhir/contributor-role", "display": "Author/Creator"}]}, "affiliation": [{"display": "Computable Publishing LLC"}], "contributor": {"type": "Practitioner", "reference": "#contributor1"}, "contributionType": [{"coding": [{"code": "formal-analysis", "system": "http://hl7.org/fhir/artifact-contribution-type", "display": "Formal analysis"}]}, {"coding": [{"code": "data-curation", "system": "http://hl7.org/fhir/artifact-contribution-type", "display": "Data curation"}]}], "forenameInitials": "J", "correspondingContact": false}, {"role": {"coding": [{"code": "author", "system": "http://hl7.org/fhir/contributor-role", "display": "Author/Creator"}]}, "affiliation": [{"display": "Computable Publishing LLC"}], "contributor": {"type": "Practitioner", "reference": "#contributor2"}, "contributionType": [{"coding": [{"code": "software", "system": "http://hl7.org/fhir/artifact-contribution-type", "display": "Software"}]}], "forenameInitials": "K", "correspondingContact": false}], "complete": true}, "publicationForm": [{"language": [{"coding": [{"system": "urn:ietf:bcp:47", "code": "en", "display": "English"}]}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "publishedIn": {"type": {"coding": [{"code": "D019991", "system": "http://terminology.hl7.org/CodeSystem/published-in-type", "display": "Database"}]}, "title": "Fast Evidence Interoperability Resources (FEvIR) Platform", "publisher": {"type": "Organization", "display": "Computable Publishing LLC"}, "publisherLocation": "Ipswich, MA, USA"}, "lastRevisionDate": "2020-12-21"}]}, "description": "This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.", "relatesTo": [{"type": "derived-from", "targetReference": {"type": "Evidence", "display": "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)", "reference": "Evidence/55"}}]}